Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from CARDIOVASCULAR PHARMACOLOGY

  • You have access
    Relationship between Phospholipase D Activation and Endothelial Vasomotor Dysfunction in Rabbit Aorta
    David A. Cox and Marlene L. Cohen
    Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 305-311;
  • You have access
    The Orally Active ETA Receptor Antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic acid (LU 135252) Prevents the Development of Pulmonary Hypertension and Endothelial Metabolic Dysfunction in Monocrotaline-Treated Rats
    Stéphane Prié, Tack Ki Leung, Peter Cernacek, James W. Ryan and Jocelyn Dupuis
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1312-1318;
  • You have access
    Role of Nitric Oxide and Ca++-Dependent K+ Channels in Mediating Heterogeneous Microvascular Responses to Acetylcholine in Different Vascular Beds
    Shawn G. Clark and Leslie C. Fuchs
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1473-1479;
  • You have access
    Superoxide Anions Contribute to Impaired Regulation of Blood Pressure by Nitric Oxide During the Development of Cardiomyopathy
    Jose A. Gutierrez, Shawn G. Clark, Ararat D. Giulumian and Leslie C. Fuchs
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1643-1649;
  • You have access
    A Comparison Between Chronotropic Effects of Neostigmine and Edrophonium in Isolated Guinea Pig Right Atrium
    Masayuki Endou, Yasuto Tanito and Fukuichiro Okumura
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1480-1486;
  • You have access
    Effects of the Glucocorticoid II Receptor Antagonist Mifepristone on Hypertension in the Obese Zucker Rat
    John C. Clapham and Nicholas C. Turner
    Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1503-1508;
  • You have access
    V2 Receptor Antagonism of DDAVP-Induced Release of Hemostasis Factors in Conscious Dogs
    A. Bernat, P. Hoffmann, A. Dumas, C. Serradeil-Le Gal, D. Raufaste and J. M. Herbert
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 597-602;
  • You have access
    Effect of Low Density Lipoprotein on Adenosine Receptor-Mediated Coronary Vasorelaxation in Vitro
    Worku Abebe and S. Jamal Mustafa
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 851-857;
  • You have access
    Disposition of Vessel Dilator and Long-Acting Natriuretic Peptide in Healthy Humans after a One-Hour Infusion
    Bruce H. Ackerman, Rose M. Overton, Michael T. McCormick, Douglas D. Schocken and David L. Vesely
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 603-608;
  • You have access
    Possible Mechanism of Action of AE0047, a Calcium Antagonist, on Triglyceride Metabolism
    Kazutaka Hayashi, Maki Gohda, Sumio Matzno, Yoshiji Kubo, Hideaki Kido, Takeshi Yamauchi and Norifumi Nakamura
    Journal of Pharmacology and Experimental Therapeutics August 1997, 282 (2) 882-890;

Pages

  • Previous
  • Next
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 13
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics